Xenikos' Series B Round

Xenikos raised a round of funding on May 15, 2018.

Xenikos is developing new immunotherapies based on conjugate Antibodies are based and the health and quality of life of patients to improve. This therapeutic approach contributes to this at, the patie…

Articles about Xenikos' Series B Round: